Wyeth Files Simultaneous NDAs For Women’s Health Treatments
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth's two submissions include desvenlafaxine succinate for treatment of vasomotor symptoms and bazedoxifene for osteoporosis.